Monkeypox Vaccine Equity Pilot Program | Monkeypox | Poxvirus | CDC - ISS-G20 Laboratorium Repository

Equity-focused vaccine projects present an opportunity to pilot creative ways to reach populations who are most affected by monkeypox virus, while contributing to our knowledge of best practices in this current outbreak. Dedicated efforts may reach populations who face barriers to awareness, education, and prevention measures like vaccination. Barriers could include differences in language, location of vaccination sites, vaccine hesitancy, mistrust of government, and lack of access to on-line scheduling technology. Additionally, affected individuals may avoid accessing vaccination at events oriented toward specific sexual or gender identities or sexual activity out of fear of being stigmatized. The Monkeypox Vaccine Equity Pilot Program was developed to demonstrate new, innovative, and non-traditional ways to address vaccination disparities within populations who are most affected.

Entire content available on: https://www.cdc.gov/poxvirus/monkeypox/health-departments/vaccine-equity-pilot.html